OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Long-Term Outcomes and Exploratory Analyses of the Randomized Phase III BILCAP Study
John Bridgewater, Peter Fletcher, Daniel H. Palmer, et al.
Journal of Clinical Oncology (2022) Vol. 40, Iss. 18, pp. 2048-2057
Open Access | Times Cited: 128

Showing 26-50 of 128 citing articles:

S3-Leitlinie Diagnostik und Therapie biliärer Karzinome – Langversion
Sabrina Groß, Michael Bitzer, Jörg Albert, et al.
Zeitschrift für Gastroenterologie (2025) Vol. 63, Iss. 02, pp. e82-e158
Closed Access

Neoadjuvant Multiagent Systemic Therapy Approach to Liver Transplantation for Perihilar Cholangiocarcinoma
Nadine Soliman, Ashton A. Connor, Ashish Saharia, et al.
Transplantation Direct (2025) Vol. 11, Iss. 3, pp. e1760-e1760
Open Access

Recurrence Patterns and Prediction of Survival After Recurrence for Gallbladder Cancer
Giovanni Catalano, Laura Alaimo, Odysseas P. Chatzipanagiotou, et al.
Journal of Gastrointestinal Surgery (2025), pp. 101997-101997
Closed Access

Evaluation of the validity of pancreatoduodenectomy for octogenarian patients with biliary tract carcinoma from the perspective of recurrence
Wataru Izumo, Hiromichi Kawaida, Ryo� Saito, et al.
Scandinavian Journal of Gastroenterology (2025), pp. 1-10
Closed Access

Chirurgia del colangiocarcinoma intraepatico e perilare
A. Facque, Nicolas Golse
EMC - Tecniche Chirurgiche Addominale (2025) Vol. 31, Iss. 1, pp. 1-18
Closed Access

The aberrant expression of CD39 is associated with the dismal outcome of patients with cholangiocarcinoma
Bohao Zheng, Sheng Shen, Jiwen Wang, et al.
Clinical Cancer Bulletin (2025) Vol. 4, Iss. 1
Open Access

Adjuvant Chemotherapy Compared to Observation in Resected Biliary Tract Cancers: Survival Meta-Analysis of Phase-III Randomized Controlled Trials
Erman Akkuş, Ángela Lamarca
European Journal of Cancer (2025) Vol. 220, pp. 115342-115342
Closed Access

S3-Leitlinie Diagnostik und Therapie des Hepatozellulären Karzinoms – Langversion
Michael Bitzer, Sabrina Groß, Jörg Albert, et al.
Zeitschrift für Gastroenterologie (2025) Vol. 63, Iss. 03, pp. e159-e260
Closed Access

Molecular Testing and Targeted Therapies in Hepatobiliary Cancers
Diamantis I. Tsilimigras, Razelle Kurzrock, Timothy M. Pawlik
JAMA Surgery (2025)
Closed Access

Das intrahepatische Cholangiokarzinom als eigenständige Entität
Aaron Schindler, Florian von van Bömmel, Thomas Berg
Im Focus Onkologie (2025) Vol. 28, Iss. 2, pp. 22-29
Closed Access

Leukocytosis and a Rare Gallbladder Sarcomatoid Carcinoma: A Case Report
Hung-Kuang Wei, Ko-Hung Shen, Chien‐Ting Chen
Journal of Cancer Research and Practice (2025) Vol. 12, Iss. 1, pp. 24-28
Open Access

Adjuvant therapy of biliary tract cancers
Joanna Kefas, John Bridgewater, Arndt Vogel, et al.
Therapeutic Advances in Medical Oncology (2023) Vol. 15
Open Access | Times Cited: 10

CDK4/6 Inhibitors in Pancreatobiliary Cancers: Opportunities and Challenges
Tatjana Arsenijevic, Katia Coulonval, Eric Raspé, et al.
Cancers (2023) Vol. 15, Iss. 3, pp. 968-968
Open Access | Times Cited: 9

S3-Leitlinie „Diagnostik und Therapie biliärer Karzinome“ – Langversion 4.0
Sabrina Groß, Michael Bitzer, Jörg Albert, et al.
Zeitschrift für Gastroenterologie (2024) Vol. 62, Iss. 02, pp. e213-e282
Open Access | Times Cited: 3

Sex differences in the pharmacokinetics of anticancer drugs: a systematic review
J Delahousse, Dorothea Wagner, Sven Borchmann, et al.
ESMO Open (2024) Vol. 9, Iss. 12, pp. 104002-104002
Open Access | Times Cited: 3

Optimizing Patient Pathways in Advanced Biliary Tract Cancers: Recent Advances and a French Perspective
Cindy Neuzillet, Pascal Artru, Eric Assénat, et al.
Targeted Oncology (2023) Vol. 18, Iss. 1, pp. 51-76
Open Access | Times Cited: 8

Revealing the Heterogeneity of the Tumor Ecosystem of Cholangiocarcinoma through Single-Cell Transcriptomics
Jihye L. Golino, Xin Wang, Hoyoung Maeng, et al.
Cells (2023) Vol. 12, Iss. 6, pp. 862-862
Open Access | Times Cited: 7

Trends in Receipt of Adjuvant Chemotherapy and its Impact on Survival in Resected Biliary Tract Cancers
Kristen E. Rhodin, Annie Liu, Alex J. Bartholomew, et al.
Annals of Surgical Oncology (2023) Vol. 30, Iss. 8, pp. 4813-4821
Closed Access | Times Cited: 7

Annals of Surgical Oncology Practice Guidelines Series: Management of Primary Liver and Biliary Tract Cancers
Samantha M. Ruff, Jordan M. Cloyd, Timothy M. Pawlik
Annals of Surgical Oncology (2023) Vol. 30, Iss. 13, pp. 7935-7949
Closed Access | Times Cited: 7

S3-Leitlinie „Diagnostik und Therapie des Hepatozellulären Karzinoms“ – Langversion 4.0
Michael Bitzer, Sabrina Groß, Jörg Albert, et al.
Zeitschrift für Gastroenterologie (2024) Vol. 62, Iss. 01, pp. e67-e161
Open Access | Times Cited: 2

SOAT1 in gallbladder cancer: Clinicopathological significance and avasimibe therapeutics
Yuqun Hong, Xiahenazi Abudukeremu, Feifei She, et al.
Journal of Biochemical and Molecular Toxicology (2024) Vol. 38, Iss. 6
Closed Access | Times Cited: 2

Scroll to top